This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Neel Desai
Executive Director, Business Development & Licensing at Biogen
Speaker

Profile

Neel Desai is an Executive Director in the Business Development group and has been with Biogen for over 7 years. During his time at the company, he has worked on multiple transactions across multiple therapeutic / disease areas such as neurodegeneration, immunology, nephrology, and multiple sclerosis. Prior to joining Biogen, Neel held a variety of roles at Piramal Life Sciences, AstraZeneca, and Vertex Pharmaceuticals. He also holds an MBA and a Masters degree in the biosciences.

Agenda Sessions

  • Engineering Value – Crafting BD Strategies that Win in Rare Disease

    9:45am